rheumatoid arthritis
Scipher Medicine to Expand Arthritis Therapy Response Test, Aiming to Maximize Medicare Coverage
Premium
The company is collecting the data necessary to add at least two other drugs to its current TNFi response predictor, which it believes will accelerate adoption.
Local Coverage Determinations Roundup: Scipher Medicine, Veracyte, Sonic Healthcare USA
A roundup of local coverage determinations from Medicare administrative contractors.
The German tools company has used its peptide microarray technology to develop a set of markers that could help with early detection of the disease.
Myriad Genetics Settles Anti-Kickback Lawsuit Related to Vectra DA
Myriad will pay $45.25 million to the federal and California state governments and $2.75 million to the whistleblower in exchange for dismissal of the case and all claims against it.
The company is hoping to gain a local coverage determination from CMS this year as it solidifies data for its first assay and works on building out a larger menu.
Feb 24, 2022
Scipher Medicine Nabs $110M in Financing
Mar 24, 2021
Scipher Medicine Raises $82M in Series C Financing
May 11, 2020
Exagen Q1 Revenues Grow 3 Percent
Apr 25, 2020
Genalyte Acquires BaseHealth
Dec 19, 2019
Scipher Medicine Closes Series B Funding Round
Nov 25, 2019
Feb 14, 2019